Biotech

All Articles

Amgen documents very first stage 3 win for $400M dermatitis medicine

.Amgen has actually discussed (PDF) the 1st stage 3 information on its $400 thousand dermatitis medi...

Biogen, UCB file stage 3 lupus win after falling short earlier trial

.Biogen as well as UCB's bet one's bottom dollar improving in to phase 3 astride a failed research s...

Aptadir hopes new RNA inhibitors may reverse difficult cancers

.Italian biotech Aptadir Therapies has actually launched with the commitment that its pipeline of pr...

Wave surfs DMD effectiveness to regulators' doors, sending out stock up

.Wave Life Sciences has actually fulfilled its goal in a Duchenne muscular dystrophy (DMD) research ...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma crease, ta...

Achilles droplets cell therapy system, braces for layoffs after missing out on 'business feasibility' goals

.Achilles Therapeutics has destroyed its own approach. The British biotech is actually stopping work...

Aligos advertises period 2 MASH gain, slashing liver fat approximately 46%

.Aligos Rehabs is heralding a midstage succeed in metabolic-dysfunction affiliated steatohepatitis (...

Basilea scores $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's job building brand-new antifungals has actually received a considerable boo...

Capricor sells Europe liberties to late-stage DMD treatment for $35M

.Possessing already scooped up the USA legal rights to Capricor Therapeutics' late-stage Duchenne mu...

FDA scraps adcomm for Applied's rare ailment drug

.After pushing the selection meeting for Applied Rehabs' metabolic ailment drug govorestat, the FDA ...